Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 4
2010 1
2011 3
2012 1
2013 2
2014 5
2015 3
2016 5
2017 4
2018 4
2019 1
2020 5
2021 5
2022 9
2023 4
2024 12
2025 9
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.
Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, Gabriele M, Lo Casto A, Lo Muzio L, Marcianò A, Mascitti M, Meleti M, Mignogna MD, Oteri G, Panzarella V, Romeo U, Santarelli A, Vescovi P, Marchetti C, Bedogni A. Campisi G, et al. Among authors: fusco v. Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998. Int J Environ Res Public Health. 2020. PMID: 32824826 Free PMC article.
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.
Zambelli A, Gerosa R, Cinquini M, Di Maio M, Miglietta F, Arecco L, Biganzoli L, Bernardi D, Cortesi L, Del Mastro L, Dieci MV, Foglietta J, Fortunato L, Franco P, Mantellini P, Marchiò C, Meduri B, Micallo G, Musolino A, Salvetti A, Santini D, Lanzetta G, Cosentini D, Bertoldo F, Cazzato RL, Cellini F, Denaro V, Di Martino A, Fusco V, Greco C, Ibrahim T, Maccauro G, DeFeo G, Severi S, Gori S. Zambelli A, et al. Among authors: fusco v. Tumori. 2025 Oct;111(5):366-378. doi: 10.1177/03008916251367339. Epub 2025 Sep 15. Tumori. 2025. PMID: 40947910
Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study.
Mauceri R, La Mantia G, Di Fede O, Fusco V, Marcianò A, Coppini M, Seminara G, Panzarella V, Coniglio R, Pizzo G, Tozzo P, Matranga D, Maniscalco L, Oteri G, Campisi G. Mauceri R, et al. Among authors: fusco v. Support Care Cancer. 2026 Jan 28;34(2):135. doi: 10.1007/s00520-025-10302-5. Support Care Cancer. 2026. PMID: 41593256 Free PMC article.
Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study.
Mauceri R, Coppini M, Marchese SM, Mauceri N, Coniglio R, Nisi M, Mauceri ME, Fusco V, Valerio MR, Campisi G. Mauceri R, et al. Among authors: fusco v. Front Oral Health. 2025 Oct 31;6:1683722. doi: 10.3389/froh.2025.1683722. eCollection 2025. Front Oral Health. 2025. PMID: 41245558 Free PMC article.
RE: MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ).
Bedogni A, Fusco V, Di Fede O, Bettini G, Panzarella V, Mauceri R, Saia G, Campisi G. Bedogni A, et al. Among authors: fusco v. J Oral Maxillofac Surg. 2022 Jan;80(1):2-3. doi: 10.1016/j.joms.2021.09.021. Epub 2021 Oct 16. J Oral Maxillofac Surg. 2022. PMID: 34666036 No abstract available.
Adjuvant denosumab in early breast-cancer.
Fusco V, Campisi G, Bedogni A. Fusco V, et al. Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8. Lancet Oncol. 2020. PMID: 32135108 Free article. No abstract available.
76 results